PMID: 9167333Nov 1, 1996Paper

Methotrexate for psoriasis

Clinical and Experimental Dermatology
M J Boffa, R J Chalmers

Abstract

Methotrexate is an effective antipsoriatic agent and has been widely used to treat severe psoriasis since the 1960s. It is especially useful in acute generalized pustular psoriasis, psoriatic erythroderma, psoriatic arthritis and for extensive chronic plaque psoriasis in patients who are inadequately controlled by topical therapy alone. It has not, however, been formally compared with other systemic treatments for severe psoriasis such as cyclosporin, retinoids or photochemotherapy with psoralen and UVA (PUVA), but in comparison with these other therapies it is inexpensive, with correct use, its safety profile is favourable. In summary, therefore, it can be used as a short-term option to gain control of unstable psoriasis such as pustular psoriasis or erythroderma before returning to other modes of treatment, or more often, as long-term maintenance treatment. The most important potential side-effect is acute myelosuppression, which is the cause of most of the rare deaths attributable to this therapy for psoriasis. Myelosuppression is more likely in the elderly, in patients with renal impairment and/or folate depletion, and with overdose or drug interactions. Long-term therapy carries with it a risk of liver fibrosis which is re...Continue Reading

References

Feb 1, 1977·Annals of Internal Medicine·G D Weinstein
Oct 1, 1979·Archives of Dermatology·W J Lewis, J F Walter
Jul 1, 1975·The British Journal of Dermatology·E From
Mar 1, 1992·The American Journal of Medicine·M H EllmanA F Turner
Jul 1, 1992·Clinical and Experimental Dermatology·P Collins, S Rogers
Mar 1, 1991·The British Journal of Dermatology·J L Burton
Aug 1, 1991·Journal of the American Academy of Dermatology·E A Olsen
Nov 1, 1991·Gastroenterology·M M Kaplan, T A Knox
Jan 1, 1990·Dermatologica·H ZachariaeT S Olsen
Oct 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M M Kaplan
Sep 1, 1990·Clinical and Experimental Dermatology·H Groenendal, F H Rampen
Mar 1, 1990·Journal of the American Academy of Dermatology·M D ZanolliA E Hedberg
Mar 25, 1989·BMJ : British Medical Journal·G M FairrisM J Campbell
Apr 1, 1989·The British Journal of Dermatology·B J Liddle, J R Marsden
Jun 14, 1986·Lancet·R R SinghJ S Guleria
Jul 1, 1988·Journal of the American Academy of Dermatology·H H RoenigkG D Weinstein
Sep 1, 1988·The British Journal of Dermatology·J RisteliH Zachariae
Mar 10, 1988·The New England Journal of Medicine·M F MullarkeyC E Wetzel
Jul 1, 1987·Clinical and Experimental Dermatology·D MitchellR J Chalmers
Jan 1, 1987·International Journal of Dermatology·G LisbyG L Wantzin
Apr 1, 1987·The British Journal of Dermatology·B S BakerL Fry
May 1, 1987·The British Journal of Dermatology·J M GommansB E van Huystee
Dec 1, 1987·Journal of the American Academy of Dermatology·D R ThomasR D Camp
Aug 1, 1987·The Journal of Investigative Dermatology·T TernowitzK Kragballe
Jan 1, 1987·Dermatologica·H Zachariae, H Søgaard
Sep 1, 1987·The British Journal of Dermatology·M RademakerD D Munro
Jun 1, 1986·The British Journal of Dermatology·H M DalyC J Roberts
Feb 1, 1987·Journal of the American Academy of Dermatology·T J PhillipsH Baker
Jan 1, 1985·Clinical and Experimental Dermatology·J Hendel, A Nyfors
May 1, 1985·Clinical and Experimental Dermatology·P C van de KerkhofJ W Mali
Dec 7, 1968·Lancet·J Allison
Aug 1, 1974·Annals of Internal Medicine·A L MetzgerC M Pearson
Mar 11, 1972·British Medical Journal·M G DahlP J Scheuer

❮ Previous
Next ❯

Citations

Apr 21, 1999·The Journal of Dermatology·A OzawaH Ogawa
Sep 1, 1999·The British Journal of Dermatology·C M ClarkC E Griffiths
Apr 30, 2002·American Journal of Clinical Dermatology·Jennifer Cather, Alan Menter
Dec 14, 2005·American Journal of Clinical Dermatology·James A Thomas, Guruprasad P Aithal
Dec 4, 2012·Dermatology and Therapy·Bruce E StroberMelodie Young
Feb 16, 2019·Drug Development and Industrial Pharmacy·Priyadarshini SatheWahid Khan
Feb 15, 2020·Expert Opinion on Drug Safety·Roberta Di CaprioAnna Balato
Nov 13, 2001·American Journal of Clinical Dermatology·A L Kuijpers, P C van de Kerkhof
Mar 9, 2005·Journal of the European Academy of Dermatology and Venereology : JEADV·M J Boffa
Jan 13, 2011·Journal of Clinical Gastroenterology·Nilesh ChandeJames Gregor
Jul 21, 2016·Clinical and Experimental Medicine·Tamilselvi ElangoPushpa Gnanaraj
Apr 5, 2018·Drugs·Musaab Elmamoun, Vinod Chandran
Jul 24, 2018·Expert Opinion on Biological Therapy·Vito Di Lernia, Mohamad Goldust
Oct 16, 2018·The British Journal of Dermatology·Z Chen
Feb 3, 2019·BMJ Case Reports·Geetha KrishnamoorthyJason Pimentel
Apr 24, 1999·The British Journal of Dermatology·B Kirby, P V Harrison
Jan 28, 2005·The Journal of Dermatology·Bhushan KumarInderjeet Kaur
Jun 13, 2020·Dermatology and Therapy·Deepak M W BalakLaura Salgado-Boquete
Dec 1, 2005·BMC Dermatology·Joseph MathewAlastair D Burt
May 30, 2006·British Journal of Hospital Medicine·Robert M Burd
Jun 12, 2012·Dermatology Research and Practice·Jillian W Wong, John Y M Koo
Sep 24, 2005·Journal of Mass Spectrometry : JMS·Petr FrycákKarel Lemr
Jun 18, 2009·American Journal of Therapeutics·Pratapji ThakorWilliam Jorgensen
Feb 9, 2012·The Australasian Journal of Dermatology·Su-ming WongRoshidah Baba
Jun 10, 2004·Dermatologic Therapy·Erin M Warshaw
Mar 8, 2003·Ophthalmology·Heather A MaustPeter J Savino
Dec 4, 2021·Zeitschrift für Rheumatologie·Denise Passens, Jörg F Schlaak

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.